Search Results - "Bunea, H"

Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy by Sörensen, A., Carles, M., Bunea, H., Majerus, L., Stoykow, C., Nicolay, N. H., Wiedenmann, N. E., Vaupel, P., Meyer, P. T., Grosu, A. L., Mix, M.

“…Purpose The aim of this study was to investigate whether textural features of tumour hypoxia, assessed with serial [ 18 F]fluoromisonidazole (FMISO)-PET, were…”
Get full text

Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region by Lazzeroni, M, Toma-Dasu, I, Ureba, A, Schiavo, F, Wiedenmann, N, Bunea, H, Thomann, B, Baltas, D, Mix, M, Stoykow, C, Sörensen, A, Grosu, A L

“…Tumor hypoxia may play a fundamental role in determining the radiotherapy outcome for several cancer types. Functional imaging with hypoxia specific…”
Get more information

PO-114: Alterations in tumour hypoxia in serial FMISO/PET-CT during chemoradiation in HNSCC by Bunea, H, Bunea, A, Majerus, L, Stoykow, C, Mix, M, Grosu, A.L

Get full text

PO-113: Dynamics of biological imaging parameters in PW-MRI and FMISO-PET/CT during chemoradiation of SCCHN by Bunea, A, Bunea, H, Stoykow, C, Majerus, L, Wiedenmann, N, Mix, M, Meyer, P, Bock, M, Grosu, A.L

Get full text

Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC by Bunea, H, Bunea, A, Wiedenmann, N, Stoykow, C, Mix, M, Majerus, L, Ludwig, U, Rischke, H.C, Langer, M, Meyer, P.T, Bock, M, Grosu, A.L

“…An abstract of the study conducted by Bunea et al detecting the dynamics of hypoxia during chemoradiation (RCTx) is with FMISO PET/CT and correlated to…”
Get full text

Dynamics in 18-Fluoromisonidazole PET/CT and Perfusion-Weighted 3-Tesla Magnetic Resonance Imaging Parameters as Biomarkers for Predicting Treatment Outcome in Head and Neck Squamous Cell Carcinoma by Bunea, H, Bunea, A, Wiedenmann, N, Stoykow, C, Mix, M, Majerus, L, Ludwig, U, Rischke, H.C, Langer, M, Meyer, P.T, Bock, M, Grosu, A

Get full text

Imaging Biomarkers Multiparametric 3 Tesla MRI and FMISO Hypoxia PET during Chemoradiotherapy in HNSCC and Their Relation to Outcome by Wiedenmann, N., Bunea, H., Rischke, H.C., Nicolay, N.H., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Bock, M., Grosu, A.L.

Get full text

EP-2030 Multiparametric MRI and FMISO PET in HNSCC and its relation with outcome by Wiedenmann, N., Bunea, H., Rischke, H., Bunea, A., Nicolay, N.H., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Bock, M., Grosu, A.

Get full text

PV-0510: FMISO-PET/CT and functional MRI parameters as biomarkers during chemoradiation of HNSCC by Bunea, H., Bunea, A., Wiedenmann, N., Stoykow, C., Mix, M., Rischke, H., Langer, M., Meyer, P., Bock, M., Grosu, A.

Get full text

EP-2296: Effect of radiochemotherapy on T2 MRI signal in HNSCC and its relation to FMISO-PET derived hypoxia by Wiedenmann, N., Bunea, H., Rischke, H., Bunea, A., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Meyer, P., Bock, M., Grosu, A.

Get full text

Effect of HNSCC Radiochemotherapy on Imaging Biomarker T2 MRI and its Relation to FMISO-PET Derived Hypoxia by Wiedenmann, N., Bunea, H., Rischke, H.C., Bunea, A., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Weber, W., Mix, M., Meyer, P.T., Hennig, J., Bock, M., Grosu, A.

Get full text

169 - Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC by Bunea, H., Bunea, A., Wiedenmann, N., Stoykow, C., Mix, M., Majerus, L., Ludwig, U., Rischke, H.C., Langer, M., Meyer, P.T., Bock, M., Grosu, A.L.

Get full text